These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25358621)

  • 1. Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    BMC Infect Dis; 2014 Oct; 14():572. PubMed ID: 25358621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
    Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
    Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
    Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of inappropriate initial antibiotics in critically ill surgical patients with bacteremia.
    Abraham K; Dolman HS; Zimmerman LH; Faris J; Edelman DA; Baylor A; Wilson RF; Tyburski JG
    Am J Surg; 2016 Mar; 211(3):593-8. PubMed ID: 26778270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.
    Leão AC; Menezes PR; Oliveira MS; Levin AS
    BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Mortality in Children with
    Choe YJ; Lee HJ; Choi EH
    Microb Drug Resist; 2019 Oct; 25(8):1210-1218. PubMed ID: 31120349
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.
    Lai HH; Liou BH; Chang YY; Kuo SC; Lee YT; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2016 Jun; 49(3):371-7. PubMed ID: 25081987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in Acinetobacter baumannii bacteremia.
    Chen HP; Chen TL; Lai CH; Fung CP; Wong WW; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2005 Apr; 38(2):127-36. PubMed ID: 15843858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia.
    Yang YS; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Lee YT
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
    Choi SH; Cho EB; Chung JW; Lee MK
    J Infect Chemother; 2019 Jan; 25(1):6-11. PubMed ID: 30342838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
    Lee YT; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Yang YS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.
    Kim YJ; Kim SI; Hong KW; Kim YR; Park YJ; Kang MW
    J Korean Med Sci; 2012 May; 27(5):471-5. PubMed ID: 22563209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
    Kim SY; Jung JY; Kang YA; Lim JE; Kim EY; Lee SK; Park SC; Chung KS; Park BH; Kim YS; Kim SK; Chang J; Park MS
    J Korean Med Sci; 2012 Aug; 27(8):939-47. PubMed ID: 22876063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
    J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable mortality of nosocomial Acinetobacter bacteremia.
    Grupper M; Sprecher H; Mashiach T; Finkelstein R
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.